How have PFSCF shares performed in 2024?

ProMetic Life Sciences' stock was trading at $5.4670 on January 1st, 2024. Since then, PFSCF stock has increased by 0.0% and is now trading at $5.4670. View the best growth stocks for 2024 here .

How do I buy shares of ProMetic Life Sciences?

Shares of PFSCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PFSCF

ProMetic Life Sciences (PFSCF) Stock Price, News & Analysis

→ With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (From DTI) (Ad)

Free PFSCF Stock Alerts

$5.47

0.00 (0.00%)

(As of 11/18/2019)

Compare

Today's Range: $5.47
▼
$5.47
50-Day Range: $5.47
▼
$5.47
52-Week Range: $5.47
▼
$352.00

Volume: N/A
Average Volume: 279 shs
Market Capitalization: $127.45 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ProMetic Life Sciences alerts:

Ad DTI

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

About ProMetic Life Sciences Stock (OTCMKTS:PFSCF)

Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.

PFSCF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PFSCF Stock News Headlines

January 29, 2023 | finance.yahoo.com

There's Been No Shortage Of Growth Recently For TMC Life Sciences Berhad's (KLSE:TMCLIFE) Returns On Capital

January 29, 2023 | reuters.com

India's Glenmark Life Sciences Q3 profit rises 1% on API strength

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

May 10, 2022 | markets.businessinsider.com

Here's what to expect from Prometic Life Sciences's earnings report

See More Headlines

Receive PFSCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProMetic Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:PFSCF
Previous Symbol: NASDAQ:PFSCF
CUSIP: N/A
CIK: N/A
Web: www.prometic.com
Phone: 1-450-781-0115
Fax: N/A
Employees: 487
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-150,730,000.00
Net Margins: -894.02%
Pretax Margin: N/A
Return on Equity: -3,350.55%
Return on Assets: -67.76%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.95
Quick Ratio: 0.71

Sales & Book Value

Annual Sales: $36.55 million
Price / Sales: 3.49
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($67.63) per share
Price / Book: -0.08

Miscellaneous

Outstanding Shares: 23,313,000
Free Float: N/A
Market Cap: $127.45 million
Optionable: Not Optionable
Beta: 2.46

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Kenneth H. Galbraith (Age 56)
CEO & Director
Mr. Bruce Pritchard
COO & Interim CFO
Mr. Patrick Sartore
Chief Legal Officer & Corp. Sec.
Mr. Bruce Wendel (Age 65)
Chief Bus. Devel. Officer
Dr. John Moran (Age 73)
Chief Medical Officer

Key Competitors

View All Competitors

PFSCF Stock Analysis - Frequently Asked Questions

How have PFSCF shares performed in 2024?: ProMetic Life Sciences' stock was trading at $5.4670 on January 1st, 2024. Since then, PFSCF stock has increased by 0.0% and is now trading at $5.4670.
View the best growth stocks for 2024 here.
How do I buy shares of ProMetic Life Sciences?: Shares of PFSCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PFSCF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial